Ligand validation:2W16

N8E: 3,6,9,12,15-PENTAOXATRICOSAN-1-OL

N8E is a Ligand Of Interest in 2W16 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2W16_N8E_A_1817	15%	70%	0.278	0.84	0.64	0.49	-	-	2	0	100%	0.5
2W16_N8E_A_1816	11%	74%	0.322	0.837	0.52	0.49	-	-	0	0	100%	1
2W76_N8E_A_1817	20%	62%	0.264	0.869	0.71	0.73	-	-	2	0	100%	0.5
2W77_N8E_A_1816	20%	73%	0.293	0.898	0.55	0.49	-	-	0	0	100%	1
2W75_N8E_A_1817	19%	68%	0.271	0.867	0.69	0.53	-	-	4	0	100%	0.5
2W6T_N8E_A_1817	18%	59%	0.277	0.862	0.75	0.81	-	-	0	0	100%	0.5
2O5P_N8E_A_11	8%	67%	0.307	0.774	0.78	0.48	1	-	0	0	100%	1
1TV5_N8E_A_1004	47%	73%	0.192	0.934	0.38	0.64	-	-	2	0	100%	1
1WDL_N8E_A_1003	11%	80%	0.299	0.818	0.4	0.43	-	-	2	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.